Medicare to Provide GLP-1 Access for Weight Loss to Older Americans Starting June 2026
Beginning June 27, 2026, older Americans will gain access to GLP-1 medications for weight loss through Medicare. Here’s what this means for eligible beneficiaries.
Editorial Staff
1 min read
Updated 16 days ago
Starting on June 27, 2026, older Americans will be able to access GLP-1 medications for weight loss under Medicare. This marks a significant development in healthcare options for this demographic.
GLP-1s are a class of medications that have shown effectiveness in aiding weight loss. Their inclusion in Medicare coverage could provide new avenues for older adults seeking to manage their weight.
As this change approaches, it is essential for eligible beneficiaries to understand the implications and benefits of this new coverage under Medicare.